ATE540042T1 - Annelierte 4-(indazolyl)-1,4- dihydropyridinderivate als c-met-mediatoren - Google Patents

Annelierte 4-(indazolyl)-1,4- dihydropyridinderivate als c-met-mediatoren

Info

Publication number
ATE540042T1
ATE540042T1 AT09761399T AT09761399T ATE540042T1 AT E540042 T1 ATE540042 T1 AT E540042T1 AT 09761399 T AT09761399 T AT 09761399T AT 09761399 T AT09761399 T AT 09761399T AT E540042 T1 ATE540042 T1 AT E540042T1
Authority
AT
Austria
Prior art keywords
met
indazolyl
annated
mediators
dihydropyridine derivatives
Prior art date
Application number
AT09761399T
Other languages
English (en)
Inventor
Martin Michels
Markus Follmann
Alexandros Vakalopoulos
Katja Zimmermann
Nicole Teusch
Karen Engel
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Application granted granted Critical
Publication of ATE540042T1 publication Critical patent/ATE540042T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT09761399T 2008-06-09 2009-05-29 Annelierte 4-(indazolyl)-1,4- dihydropyridinderivate als c-met-mediatoren ATE540042T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08010423 2008-06-09
PCT/EP2009/003837 WO2009149836A1 (en) 2008-06-09 2009-05-29 Annellated 4- (indazolyl) -1,4-dihydropyridine derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE540042T1 true ATE540042T1 (de) 2012-01-15

Family

ID=40933643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09761399T ATE540042T1 (de) 2008-06-09 2009-05-29 Annelierte 4-(indazolyl)-1,4- dihydropyridinderivate als c-met-mediatoren

Country Status (7)

Country Link
US (1) US8642595B2 (de)
EP (1) EP2300482B1 (de)
JP (1) JP5480891B2 (de)
AT (1) ATE540042T1 (de)
CA (1) CA2727199C (de)
ES (1) ES2377809T3 (de)
WO (1) WO2009149836A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2451817B1 (de) * 2009-07-10 2013-09-04 Bayer Intellectual Property GmbH Indazolyl-substituierte dihydroisoxa-zolopyridine und verfahren zu ihrer verwendung
DE102009056886A1 (de) * 2009-12-03 2011-06-09 Bayer Schering Pharma Aktiengesellschaft cMet-Inhibitoren zur Behandlung der Endometriose
JP2014500277A (ja) 2010-12-09 2014-01-09 アムジエン・インコーポレーテツド Ｐｉｍ阻害剤としての二環式化合物
WO2012129338A1 (en) 2011-03-22 2012-09-27 Amgen Inc. Azole compounds as pim inhibitors
KR102730905B1 (ko) * 2022-05-03 2024-11-15 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653313B2 (en) * 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
MXPA05002644A (es) * 2002-09-10 2005-09-20 Bayer Healthcare Ag Derivados de pirimidinona como agentes terapeuticos contra procesos de remodelacion, isquemicos e inflamatorios agudos y cronicos.
GB2392910A (en) * 2002-09-10 2004-03-17 Bayer Ag 2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors
ES2394177T3 (es) * 2004-02-26 2013-01-23 Bayer Intellectual Property Gmbh 1,4-diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos
JP4825195B2 (ja) * 2004-02-26 2011-11-30 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト １，４−ジアリール−ジヒドロピリミジン−２オン化合物およびヒト好中球エラスターゼ阻害剤としてのそれらの使用
US7723330B2 (en) * 2006-03-07 2010-05-25 Array Biopharma Inc. Heterobicyclic pyrazole compounds and methods of use
MX2008013430A (es) * 2006-04-19 2009-01-26 Novartis Vaccines & Diagnostic Compuestos de indazol y metodos para la inhibición de cdc7.
CA2672167C (en) * 2006-12-14 2016-01-26 Bayer Schering Pharma Aktiengesellschaft Dihydropyridine derivatives useful as protein kinase inhibitors

Also Published As

Publication number Publication date
CA2727199C (en) 2016-11-22
EP2300482B1 (de) 2012-01-04
US8642595B2 (en) 2014-02-04
JP2011524348A (ja) 2011-09-01
EP2300482A1 (de) 2011-03-30
CA2727199A1 (en) 2009-12-17
JP5480891B2 (ja) 2014-04-23
ES2377809T3 (es) 2012-04-02
US20110172221A1 (en) 2011-07-14
WO2009149836A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
MY148851A (en) Dihydropyridine derivatives as useful as protein kinase inhibitors
WO2009097287A9 (en) Compounds and compositions as kinase inhibitors
EA201071089A1 (ru) Производные хиназолина как модуляторы raf-киназы и способы их применения
EA201190158A1 (ru) Производные бензофуранила для применения в качестве ингибиторов глюкокиназы
EA200971077A1 (ru) Гетероциклические модуляторы киназы
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
ATE544761T1 (de) Pyrimidinderivate und zusammensetzungen als c-kit-und pdgfr-kinasehemmer
EA200901486A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
EA201100311A1 (ru) Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
EA200900983A1 (ru) Соединения и композиции в качестве ингибиторов киназы
MX2012008911A (es) Sales y polimorfos de 8-fluoro-2-{4-[(metilamino)metil]fenil}-1,3, 4,5-tetrahidro-6h-acepino[5,4,3-cd]indol-6-ona.
NO20083214L (no) Pyrimidinylarylurea-derivater som omdannes til FGF-inhibitorer
ATE497496T1 (de) 2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen
EA201270480A1 (ru) Новые соединения
MX388660B (es) DERIVADOS DE N-(SUSTITUIDA-FENIL)-SULFONAMIDA COMO INHIBIDORES DE QUINASA N-(sustituida-fenil)-sulfonamida.
EA201070618A1 (ru) 4-пиразолил-n-арилпиримидин-2-амины и 4-пиразолил-n-гетероарилпиримидин-2-амины в качестве ингибиторов киназ janus
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
ATE538114T1 (de) 4-(pyridin-4-yl)-1h-ä1,3,5ütriazin-2-onderivate als gsk3-beta-inhibitoren zur behandlung neurodegenerativer krankheiten
EA200901484A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
EA201500362A1 (ru) Ингибиторы rho-киназы
MX2009006170A (es) Compuestos y composiciones como inhibidores de cinasa.
ATE540038T1 (de) Heterocyclen als proteinkinaseinhibitoren
DE602006006985D1 (de) Pyridinderivate als pkc-theta-hemmer
PH12012500640A1 (en) Fluoro-substituted 3,5 - dicyano -4- (1h-indazol -5- yl) -2,6- dimethyl -1,4- dihydropyridine derivatives and methods of use thereof
CY1110087T1 (el) Μεθοδοι παρασκευης ενωσεων που περιεχουν πυρραζολιο